Table 4.
Factors associated with convulsion in COVID-19 patients infected by Omicron variant (multivariate analysis)
| Variable | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|
| OR (95%CI) | P | OR (95%CI) | P | OR (95%CI) | P | |
| History of febrile seizure | 12.029(4.792–30.196) | < 0.01 | 10.970(3.986–30.192) | < 0.01 | 10.359(2.115–50.746) | 0.004 |
| Cough | 0.305(0.156–0.593) | < 0.01 | 0.260(0.117–0.576) | 0.001 | 0.816(0.242–2.752) | 0.743 |
| Wheeze | 0.145(0.018–1.139) | 0.066 | ||||
| Polypnea | 0.276(0.079–0.967) | 0.044 | 0.179(0.045–0.712) | 0.015 | 0.153(0.022–1.081) | 0.060 |
| Diarrhea | 0.454(0.188–1.096) | 0.079 | ||||
| Neutrophils(× 109/L) | 1.123(1.035–1.217) | 0.005 | 1.116(1.015–1.226) | 0.023 | 1.033(0.765–1.395) | 0.831 |
| Lymphocytes(× 109/L) | 0.712(0.605–0.837) | < 0.01 | 0.756(0.621–0.920) | 0.005 | 1.335(0.894–1.996) | 0.158 |
| Eosinophils(× 109/L) | 0.012(0.001–0.184) | 0.001 | 0.139(0.013–1.476) | 0.102 | ||
| NLR | 1.261(1.135–1.401) | < 0.01 | 1.213(1.084–1.359) | 0.001 | 1.055(0.730–1.525) | 0.774 |
| MLR | 7.815(3.202–19.075) | < 0.01 | 8.464(3.033–23.616) | < 0.01 | 0.769(0.087–6.760) | 0.813 |
| Platelet(× 109/L) | 0.995(0.992–0.997) | < 0.01 | 0.997(0.994–1.000) | 0.047 | 0.996(0.988–1.005) | 0.412 |
| PLR | 1.005(1.002–1.008) | < 0.01 | 1.005(1.002–1.008) | < 0.01 | 1.003(0.991–1.015) | 0.680 |
| MPR | 5.151(0.009–3022.779) | 0.614 | ||||
| PCT(ng/mL) | 1.018(0.960–1.078) | 0.556 | ||||
| Albumin(g/L) | 1.241(1.114–1.382) | < 0.01 | 1.127(0.994–1.277) | 0.062 | ||
| ALP(U/L) | 1.004(1.000–1.007) | 0.041 | 1.010(1.005–1.015) | < 0.01 | 1.001(0.994–1.008) | 0.712 |
| lymphocyte subsets Log(/ul) | 0.172(0.078–0.377) | < 0.01 | 0.138(0.048–0.394) | < 0.01 | 9.525(0.112–54.807) | 0.687 |
| CD3+T cell count Log(/ul) | 0.179(0.087–0.371) | < 0.01 | 0.185(0.074–0.464) | < 0.01 | 0.62(0.120–16.368) | 0.779 |
| CD3+CD4+T cell count Log(/ul) | 0.198(0.103–0.383) | < 0.01 | 0.187(0.078–0.449) | < 0.01 | 0.291(0.112–11.38) | 0.819 |
| CD3+CD8+T cell count Log(/ul) | 0.237(0.117–0.480) | < 0.01 | 0.226(0.097–0.529) | 0.001 | 21.994(0.220–21.541) | 0.379 |
| CD3−CD19+ B cell count Log(/ul) | 0.552(0.288–1.059) | 0.074 | ||||
| NK count Log(/ul) | 0.255(0.127–0.512) | < 0.01 | 0.254(0.109–0.595) | 0.002 | 0.081(0.010–0.652) | 0.018 |
Abbreviations: NLR neutrophil-to-lymphocyte ratio, MLR monocyte-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio, MPR mean platelet volume-to-platelet ratio, PCT procalcitonin, ALP alkaline phosphatase, OR odds ratio, CI confidence interval. Model 1 was not adjusted. Model 2 was adjusted for age and sex. Model 3 was adjusted as Model 2 + disease course, history of convulsion, cough, polypnea, neutrophils, lymphocytes, NLR, MLR, platelet, PLR,ALP, lymphocyte, CD3+ T cell count, CD3+CD4+ T cell count, CD3+CD8+ T cell count and NK cell count